Acinetobacter baumannii is a Gram-negative
opportunistic
pathogen that causes nosocomial infections, especially among immunocompromised
individuals. The rise of multidrug resistant strains of A.
baumannii has limited the use of standard antibiotics, highlighting
a need for new drugs that exploit novel mechanisms of pathogenicity.
Disrupting iron acquisition by inhibiting the biosynthesis of iron-chelating
molecules (siderophores) secreted by the pathogen is a potential strategy
for developing new antibiotics. Here we investigated FbsI, an N-hydroxylating monooxygenase involved in the biosynthesis
of fimsbactin A, the major siderophore produced by A. baumannii. FbsI was characterized using steady-state and transient-state kinetics,
spectroscopy, X-ray crystallography, and small-angle X-ray scattering.
FbsI was found to catalyze the N-hydroxylation of
the aliphatic diamines putrescine and cadaverine. Maximum coupling
of the reductive and oxidative half-reactions occurs with putrescine,
suggesting it is the preferred (in vivo) substrate.
FbsI uses both NADPH and NADH as the reducing cofactor with a slight
preference for NADPH. The crystal structure of FbsI complexed with
NADP+ was determined at 2.2 Å resolution. The structure
exhibits the protein fold characteristic of Class B flavin-dependent
monooxygenases. FbsI is most similar in 3D structure to the cadaverine N-hydroxylases DesB and DfoA. Small-angle X-ray scattering
shows that FbsI forms a tetramer in solution like the N-hydroxylating monooxygenases of the SidA/IucD/PvdA family. A model
of putrescine docked into the active site provides insight into substrate
recognition. A mechanism for the catalytic cycle is proposed where
dehydration of the C4a-hydroxyflavin intermediate is partially rate-limiting,
and the hydroxylated putrescine product is released before NADP+.